Trastuzumab
CT-P6 3.2
Phase 3 small_molecule completed
Quick answer
Trastuzumab for HER2-positive Carcinoma of Breast is a Phase 3 program (small_molecule) at Celltrion Healthcare Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celltrion Healthcare Australia Pty Ltd
- Indication
- HER2-positive Carcinoma of Breast
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed